InnoCare Pharma Limited (HKG:9969)

InnoCare Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16,612	12,634	13,677	24,677	22,945	17,378
Market Cap Growth	-7.63%	-7.63%	-44.57%	7.55%	32.04%	-
Enterprise Value	11,688	6,527	5,233	15,518	16,987	13,835
Last Close Price	7.91	6.12	6.89	13.64	15.30	13.48
PS Ratio	12.45	11.76	16.81	34.90	17.92	10727.94
PB Ratio	1.77	1.76	1.73	2.86	3.30	4.63
P/TBV Ratio	2.33	1.78	1.81	2.98	3.36	4.78
P/OCF Ratio	-	-	-	111.89	-
EV/Sales Ratio	10.88	6.08	6.43	21.95	13.27	8540.54
Debt / Equity Ratio	0.23	0.23	0.23	0.20	0.23	0.37
Asset Turnover	0.10	0.10	0.07	0.07	0.18	0
Inventory Turnover	1.29	1.29	1.39	3.81	11.13	-
Quick Ratio	6.23	6.23	4.13	4.44	19.29	38.75
Current Ratio	7.37	7.37	4.21	4.50	19.49	39.18
Return on Equity (ROE)	-6.50%	-6.50%	-8.71%	-13.44%	-1.51%	-368.36%
Return on Assets (ROA)	-3.37%	-3.37%	-4.37%	-5.15%	-1.91%	-9.77%
Return on Capital (ROIC)	-3.80%	-3.80%	-4.91%	-5.66%	-2.02%	-10.37%
Earnings Yield	-2.82%	-3.71%	-5.08%	-4.06%	-0.34%	-2.67%
FCF Yield	-	-7.41%	-3.94%	-0.01%	-2.89%
Buyback Yield / Dilution	0.90%	0.90%	-15.46%	-8.15%	-41.21%	-321.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.